Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Certain extracts from Curcuma aeruginosa Roxb. and germacrone can boost the skin's absorption of minoxidil, a hair growth promoter, making it more effective.

PRP injections safely increase hair density and thickness in androgenetic alopecia.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

Hair restoration surgery redistributes existing hair to achieve a natural look, with visible regrowth in 3-4 months and rare complications, mostly aesthetic.

Female pattern hair loss affects 32.3% of women, increasing with age and showing no racial differences.

Finasteride harms invertebrates' survival and burial ability.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Dutasteride safely treats hair loss without harming sexual function.

Hair style affects perceptions of age, health, and attractiveness more than hair color does.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Psychotropic drugs can help treat skin conditions affected by mental health, but dermatologists must use them carefully due to side effects and patient concerns.

PRP injections may improve skin texture and wrinkles based on patient feedback, despite no significant changes seen by dermatologists.

Women with PCOS tend to be less optimistic than those without it.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Higher vitamin D levels are linked to higher iron levels in Korean women without metabolic syndrome, but not in those with it.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Testosterone's muscle-building effects do not require its conversion to DHT.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Low IGF-1 and high HDL cholesterol levels are linked to more hair loss in middle-aged women.